Astrocyte Pharmaceuticals Inc. announced that it has received $7.522677 million in funding from CR Ventures, DeepWork Capital, Trend Investment Group, Kyto Technology and Life Science, Inc. and other investors
On December 10, 2020, Astrocyte Pharmaceuticals Inc. closed the transaction. The company issued 19,615,846 shares for proceeds of $7,522,677 pursuant to Regulation D. The company received $6,000,000 led by Boston Harbor Angels, and included participation 70 investors including DeepWork Capital, CR Ventures, Trend Investment Group, Dreamers Startup Ventures, Zhi Gao Holdings, Kyto Technology and Life Science, Inc. (OTCPK:KBPH), Life Science Angels, Mass Medical Angels, Mid Atlantic Bio Angels, SideCar Angels, and others.